Survival outcomes after surgical treatment of oral squamous cell carcinoma

Oral Diseases - Tập 26 Số 7 - Trang 1432-1439 - 2020
Annelies Weckx1, Kathrin J. Grochau1, Andrea Grandoch1, Tim Backhaus1, Joachim E. Zöller1, Matthias Kreppel1
1Department for Oral and Craniomaxillofacial Plastic Surgery, University of Cologne, Cologne, Germany

Tóm tắt

AbstractObjectiveTo identify the clinicopathological parameters that influence survival in patients with oral squamous cell carcinoma, in order to allow for the development of individualized surveillance programmes and reduce the delay in diagnosis of recurrence.Materials and MethodsRetrospective chart review of 553 patients with a treatment‐naïve primary oral squamous cell carcinoma, who underwent primarily curative intended surgery. Exclusion criteria were neoadjuvant radio(chemo)therapy, follow‐up < 1 year, perioperative death, inoperable disease, synchronous multiple malignancies and inadequate information on clinicopathological parameters.ResultsThe clinicopathological factors that influence overall survival, disease‐free survival and locoregional control were calculated. In the multivariate survival analysis, the occurrence of recurrence, presence of extracapsular spread, T‐ and N‐classification were shown to be independent risk factors for overall survival.ConclusionThe identification of these risk factors can lead to the development of individualized follow‐up programmes based on risk stratification. This allows for the earliest possible diagnosis of relapse which is essential to offer the patient a realistic second treatment chance and to improve survival rates.

Từ khóa


Tài liệu tham khảo

10.1016/j.jcms.2014.01.046

10.1016/j.oraloncology.2010.01.019

10.1097/01.pas.0000149687.90710.21

Caldeira P. C., 2019, Tumor depth of invasion and prognosis of early‐stage oral squamous cell carcinoma: A meta‐analysis, Oral Diseases, 26, 1357, 10.1111/odi.13194

10.1159/000328340

10.1016/j.joms.2019.03.015

10.1002/hed.23914

10.18632/oncotarget.16340

10.1016/j.jcms.2017.02.022

10.1097/MD.0000000000003770

10.1016/j.amjoto.2012.04.006

10.1016/j.jcms.2015.05.011

10.1002/cncr.24631

10.1002/hed.21088

10.1016/j.ijom.2014.10.006

10.1186/1758-3284-2-9

10.1001/archoto.2010.214

10.1002/jso.25386

10.1016/j.oraloncology.2018.09.021

10.1016/j.jcms.2015.06.020

10.1016/j.oraloncology.2016.10.003

10.1016/j.oraloncology.2018.01.020

10.1016/j.bjoms.2017.08.362

10.1016/j.ijom.2019.03.900

10.1002/1097-0142(19910701)68:1<189::AID-CNCR2820680133>3.0.CO;2-G

10.1016/j.oraloncology.2008.05.008

10.1016/j.jcms.2017.07.012

10.1016/j.oraloncology.2018.10.015

10.1016/j.ijom.2017.02.1277

10.1016/j.joms.2011.06.228

10.1016/j.oraloncology.2019.05.002

10.1016/j.bjoms.2011.05.008

10.1016/j.oraloncology.2005.05.008

10.1016/j.ijom.2012.07.011

10.1111/odi.12101

10.1016/j.oraloncology.2019.02.001